KURE ETF

Industry-level regulatory crackdowns in China and efforts to quash corruption are notoriously hard on investors, but over time, those clampdowns can pay off. That could prove to be the case in China's fast-growing healthcare sector.

As China continues to get its economic act together, there's still room for innovation in the area of health care. It's a sector that simply won't go away and can thrive in any economic environment, opening up opportunities in exchange traded funds (ETFs) such as the KraneShares MSCI All China Health Care ETF (KURE).

China is home to one of the largest healthcare markets and, from an investment prospective, one of the most compelling in the emerging world. Among the reasons for that are a burgeoning biotechnology industry, an aging population, and increasing digitization, among other factors.